H. pylori infections occur across the world due to exposure to saliva or stool in contaminated water or food. Learn how the ...

Study finds underutilization of fidaxomicin, a recommended treatment for C. diff infection, despite increased use in hospitals.

Prior to 2021 vancomycin and metronidazole had been the recommended first-line agents for CDI, which is the most common ...

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

To measure the effect on gut bacteria, the researchers gave healthy mice either lolamicin, a placebo or one of two common antibiotics, amoxicillin and clindamycin. After collecting baseline stool ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Discover Merck's groundbreaking patent on genetic markers linked to enhanced C. difficile treatment responses. Learn how personalized therapy can improve patient outcomes.

bCentro INFANT de Medicina Traslacional (CIMeT), Escuela de Bio y Nanotecnología, Universidad Nacional de San Martín (UNSAM), Buenos Aires, Argentina cConsejo Nacional de Investigaciones Científicas y ...

The stigma linking HIV to the LGBTQ+ community led to poor funding for treatment and unfair treatment for those diagnosed with the virus in areas such as housing, work, and other parts of society.

By conducting a thorough analysis of the existing literature, we underscore the multifaceted and intricate relationship between bacteria and cancer. Understanding this complex interplay could pave the ...

“Antibiotics are used as a first-line treatment for C. diff., and while it may work for a majority of cases, a significant minority of patients will often experience a recurrent infection,” said ...

Objective: To describe emergent therapies, such as rifaximin, nitazoxanide, intravenous immunoglobulin (IVIG), tinidazole, tolevamer, and the possible use of a vaccine, in Clostridium difficile ...